‘Load Up,’ Says Jim Cramer About These 2 ‘Strong Buy’ Healthcare Stocks

Against a backdrop of soaring inflation, a slowing economy and persistent rate hikes, assessing the playbook for the coming year, CNBC’s Jim Cramer says it’s more important than ever to look at the past year and see what worked. Basically, which stocks have managed to overcome the bear conditions.

Within the components of the S&P 500, energy and utilities have been segments that have beaten the broader market, and generally speaking, so have those of the healthcare sector.

But healthcare stocks, of course, are a varied bunch, and run the gamut from Big Pharma to hospital operators to medical device makers to small biotechs yet to notch any sales. Right now, however, says the Mad Money host, of all the stocks on offer, it’s clear what the market wants.

“Wall Street likes profitable companies with consistent results, nice dividends and reasonably valued stocks,” he said. And the healthcare sector has some of those; “boring, consistent operators with cheap stocks” – these have been 2022’s winners. And such names are going to keep outperforming, according to Cramer.

With this in mind, let’s look at two big, dependable names Cramer thinks investors should be loading up on right now. We’ve used the TipRanks database to see whether the Street’s analysts agree with these picks. As it turns out, each stock has received enough bullish calls over the last three months to give it a “Strong Buy” consensus rating.

Humana Inc. (HUM)

If you are looking for big, profitable, healthcare giants, then look no further. Humana, the first Cramer pick, took the 41st spot last year on the Fortune 500 list and is currently the U.S.’s fourth biggest health insurance provider.

It also helps in the current climate that the bulk of Humana’s revenues are generated from government-sponsored programs, which provide the company with a regular and reliable income stream few can match. And in the difficult current climate that has been a real boon, as was clear to see in the latest earnings report.

Story continues

Q3 revenue grew by 10.16% year-over-year to $22.80 billion,…

..

Read More

Recommended For You

Leave a Reply

Your email address will not be published. Required fields are marked *